Vera Therapeutics, Inc（VERA）价格预测

$34.230

+0.151 (+0.44%)收盘时

价格预测

1-Day Price Prediction

+0.69%

1-Week Prediction

+0.87%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

VERA 相似图表分析预测

Alphio's VERA stock price prediction model matches the current Vera Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $34.47 (+0.69%). The 1-week path is $34.53 (+0.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Vera Therapeutics, Inc 股票吗？

Vera Therapeutics is a good buy right now due to its recent FDA accelerated approval for TRUTAKNA, which demonstrated a 46% reduction in proteinuria, a significant advancement in treating chronic kidney disease. The current price of $34.19 is well below the average analyst price target of $76, indicating substantial upside potential. However, the company has reported a negative EPS of -1.52, which highlights ongoing financial challenges that investors should consider.

VERA 股价于 Tuesday 收于 $34.23，此前上涨 +0.44%

Vera Therapeutics, Inc (VERA) last closed at $34.23, gaining +0.44%. These facts feed the 1-day and 1-week VERA price prediction above.

预测驱动因素

Vera Therapeutics, Inc（VERA）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 VERA 最接近的股票，按相似度排序。

BRO

90.86%

+6.16%

GXO

90.48%

-18.03%

90.32%

-3.59%

ODFL

90.27%

-5.82%

VNT

89.87%

-24.85%

VERA 季节性分析

Historically the probability of a positive September return for VERA is 47.62%. December offers the highest probability of a positive month at 93.02%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…